Intuitive Surgical dominates the robotic-assisted surgery market with the da Vinci system. Despite challenges like declining bariatric surgeries, the company remains resilient, with consistent revenue growth. Its underpenetrated market and strong moat make it a solid long-term investment for younger investors seeking substantial returns.

Moderna, known for its successful COVID-19 vaccine, has a promising mRNA platform for faster and cheaper vaccine development. Despite recent stock lagging due to declining coronavirus vaccine sales, the company’s pipeline, including a personalized cancer vaccine, holds significant potential for growth. Riskier but rewarding for young investors.

Investing styles evolve with age. Seniors seek steady dividends, while younger investors can take risks for long-term gains. Consider Intuitive Surgical and Moderna for substantial returns. Intuitive Surgical leads in robotic-assisted surgery, while Moderna’s innovative vaccine platform and pipeline offer significant upside potential. Both stocks cater to different investor preferences based on age and risk tolerance.

Read more at Yahoo Finance: If You’re in Your 30s, Consider Buying These 2 Healthcare Stocks